Synthesis, oligomerization, and biological activity of the human immunodeficiency virus type 2 envelope glycoprotein expressed by a recombinant vaccinia virus

Virology. 1990 Sep;178(1):134-42. doi: 10.1016/0042-6822(90)90386-6.

Abstract

The full-length envelope gene from an infectious human immunodeficiency virus type 2 (HIV-2) molecular clone was expressed in CD4+ and CD4- cells by a recombinant vaccinia virus vector. Pulse-chase experiments indicated that gp160 was processed into gp120 and gp41 subunits. Although large amounts of gp120 were shed into the medium, the recombinant vaccinia virus-infected cells fused with uninfected CD4+ cells. The receptor binding of HIV-2 gp120 was further analyzed using a panel composed of nine soluble CD4 mutants containing insertions of 2 amino acids within the first and second immunoglobulin-like domains. Of three mutations previously shown to interfere with HIV-1 gp120 binding, two also interfered with binding of the HIV-2 glycoprotein indicating use of the same binding site. Chemical crosslinking, sucrose gradient sedimentation, and sodium dodecyl sulfate-polyacrylamide gel electrophoresis were employed to study the oligomerization of the envelope protein. The data indicated that gp160 assembles posttranslationally into dimers and higher oligomers that are probably tetramers.

MeSH terms

  • Animals
  • CD4 Antigens / genetics
  • CD4 Antigens / immunology
  • Cloning, Molecular
  • Cross-Linking Reagents / metabolism
  • Cytopathogenic Effect, Viral
  • HIV Envelope Protein gp120 / genetics
  • HIV Envelope Protein gp120 / immunology*
  • HIV Envelope Protein gp41 / genetics
  • HIV Envelope Protein gp41 / immunology
  • HIV-2 / genetics
  • HIV-2 / metabolism
  • Haplorhini
  • Humans
  • Mutation
  • Protein Processing, Post-Translational
  • Receptors, Virus / immunology
  • Solubility
  • Vaccinia virus / genetics*

Substances

  • CD4 Antigens
  • Cross-Linking Reagents
  • HIV Envelope Protein gp120
  • HIV Envelope Protein gp41
  • Receptors, Virus